Named on 23 rounds in the feed, most often at Series D+ and in AI.
Rounds from 2015-10-06 to 2026-11-05
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Nova Anchora A biotechnology company developing a corrective topical protein therapy for dystrophic epidermolysis bullosa (DEB) | Funding round Verified against 4 of 12 sources | $23M | 2026-11-05 | [ LEAD ] |
nPhase A clinical research technology company that connects clinical trial and real-world data into a single foundation for clinical decision-making | Series D Verified against 1 of 56 sources | $30M | 2026-11-02 | [ LEAD ] |
TriGemX Bio A biotechnology company focused on developing a medicines for the treatment of migraine | Funding round Verified against 4 of 11 sources | $94M | 2026-10-01 | [ LEAD ] |
Pearl Health Pearlhealth offers technology and analytics solutions for healthcare organizations to succeed in value-based care. | Series C Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $110M | 2026-07-07 | [ PART ] |
AlphaSense AlphaSense sells a market intelligence platform powered by AI, primarily for corporate and financial analysis. | Funding round Verified against 4 of 16 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $350M | 2026-06-03 | [ PART ] |
Diagonal Therapeutics They develop innovative clustering antibodies for the treatment of genetic diseases. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $125M | 2026-01-08 | [ PART ] |
Veradermics Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company. | Series C Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $150M | 2025-10-16 | [ PART ] |
STAR Therapeutics They develop and provide antibody therapies for patients with serious diseases. | Series D Verified against 2 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $125M | 2025-09-30 | [ LEAD ] |
Canopy Tax Cloud-based practice management platform | Series C Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $70M | 2025-04-23 | [ LEAD ] |
Neurona Therapeutics Cell therapies for targeted repair of dysfunctional neural circuits underlying chronic neurological diseases. | Funding round Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $102M | 2025-04-03 | [ PART ] |
AlphaSense AlphaSense sells a market intelligence platform powered by AI, primarily for corporate and financial analysis. | Funding round Verified against 1 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $650M | 2024-06-11 | [ LEAD ] |
Diagonal Therapeutics They develop innovative clustering antibodies for the treatment of genetic diseases. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $128M | 2024-04-03 | [ PART ] |
Neurona Therapeutics Cell therapies for targeted repair of dysfunctional neural circuits underlying chronic neurological diseases. | Seed Developing, 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $120M | 2024-02-08 | [ LEAD ] |
AlphaSense AlphaSense sells a market intelligence platform powered by AI, primarily for corporate and financial analysis. | Series E Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $150M | 2023-09-28 | [ PART ] |
Lightmatter Lightmatter sells photonic chips and interconnect solutions specifically designed for AI supercomputers, targeting AI infrastructure and data centers. | Series C Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $155M | 2023-05-31 | [ LEAD ] |
AlphaSense AlphaSense sells a market intelligence platform powered by AI, primarily for corporate and financial analysis. | Series D Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2023-04-11 | [ PART ] |
Arctic Wolf Arctic Wolf sells managed detection and response (MDR) services and cybersecurity solutions to businesses, enhancing their security posture against cyber threats. | Convertible Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $401M | 2022-10-06 | [ PART ] |
AlphaSense AlphaSense sells a market intelligence platform powered by AI, primarily for corporate and financial analysis. | Series D+ Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $225M | 2022-06-15 | [ LEAD ] |
AlphaSense AlphaSense sells a market intelligence platform powered by AI, primarily for corporate and financial analysis. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $180M | 2021-09-30 | [ LEAD ] |
Clip Clip sells digital payment solutions including point-of-sale terminals, mobile payment acceptance, and business management tools for small and medium-sized businesses. | Funding round Verified against 1 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $250M | 2021-06-10 | [ LEAD ] |
Lightmatter Lightmatter sells photonic chips and interconnect solutions specifically designed for AI supercomputers, targeting AI infrastructure and data centers. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $80M | 2021-05-06 | [ LEAD ] |
Arctic Wolf Arctic Wolf sells managed detection and response (MDR) services and cybersecurity solutions to businesses, enhancing their security posture against cyber threats. | Series E Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $200M | 2020-10-22 | [ LEAD ] |
Impossible Foods Impossible Foods sells plant-based meat alternatives to consumers and businesses. | Series D+ Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $108M | 2015-10-06 | [ PART ] |